bluebird bio, Inc. Lease, Cost
bluebird bio, Inc. reported Lease, Cost of $35.98 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2025-05-14
- bluebird bio, Inc. lease, cost for the quarter ending 2025-03-31 was $35.98M, a 4.96% increase year-over-year.
- bluebird bio, Inc. lease, cost for the quarter ending 2024-12-31 was $30.76M, a 11.65% increase year-over-year.
- bluebird bio, Inc. lease, cost for the quarter ending 2024-09-30 was $35.27M, a 33.25% increase year-over-year.
- bluebird bio, Inc. lease, cost for the quarter ending 2024-06-30 was $34.51M, a 34.90% increase year-over-year.
- bluebird bio, Inc. lease, cost for fiscal 2024 was $134.93M, a 25.55% increase from fiscal 2023.
- bluebird bio, Inc. lease, cost for fiscal 2023 was $107.47M, a 44.00% increase from fiscal 2022.
- bluebird bio, Inc. lease, cost for fiscal 2022 was $74.64M, a 197.75% increase from fiscal 2021.
- bluebird bio, Inc. lease, cost for fiscal 2021 was $25.07M, a 34.34% increase from fiscal 2020.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month | Lease, Cost 12 month as first filed | Lease, Cost 842 month |
|---|---|---|---|---|---|---|
| 2025-03-31 | $35.98M 10-Q · filed 2025-05-14 | $66.74M derived: sum of 2 quarters · filed 2025-05-14 | $102.01M derived: sum of 3 quarters · filed 2025-05-14 | $136.53M derived: sum of 4 quarters · filed 2025-05-14 | ||
| 2024-12-31 | $30.76M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $66.03M derived: sum of 2 quarters · filed 2025-03-27 | $100.55M derived: sum of 3 quarters · filed 2025-03-27 | $134.93M 10-K · filed 2025-03-27 | ||
| 2024-09-30 | $35.27M 10-Q · filed 2024-11-14 | $69.78M derived: sum of 2 quarters · filed 2024-11-14 | $104.17M 10-Q · filed 2024-11-14 | $131.62M derived: sum of 4 quarters · filed 2025-05-14 | ||
| 2024-06-30 | $34.51M 10-Q · filed 2024-09-27 | $68.89M 10-Q · filed 2024-09-27 | $96.35M derived: sum of 3 quarters · filed 2025-05-14 | $122.81M derived: sum of 4 quarters · filed 2025-05-14 | ||
| 2024-03-31 | $34.28M 10-Q · filed 2025-05-14 | $61.83M derived: sum of 2 quarters · filed 2025-05-14 | $88.30M derived: sum of 3 quarters · filed 2025-05-14 | $113.89M derived: sum of 4 quarters · filed 2025-05-14 | ||
| 2023-12-31 | $27.55M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $54.02M derived: sum of 2 quarters · filed 2025-03-27 | $79.61M derived: sum of 3 quarters · filed 2025-03-27 | $107.47M 10-K · filed 2025-03-27 | ||
| 2023-09-30 | $26.47M 10-Q · filed 2024-11-14 | $52.05M derived: sum of 2 quarters · filed 2024-11-14 | $79.92M 10-Q · filed 2024-11-14 | |||
| 2023-06-30 | $25.59M 10-Q · filed 2024-09-27 | $53.45M 10-Q · filed 2024-09-27 | ||||
| 2023-03-31 | $27.87M 10-Q · filed 2024-09-13 | |||||
| 2022-12-31 | $74.64M 10-K · filed 2024-09-13 | $56.10M 10-K · filed 2023-03-29 | ||||
| 2021-12-31 | $25.07M 10-K · filed 2023-03-29 | |||||
| 2020-12-31 | $18.66M 10-K · filed 2023-03-29 | $35.05M 10-K · filed 2021-02-23 | ||||
| 2019-12-31 | -$6.24M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-04 | $2.60M derived: sum of 2 quarters · filed 2022-03-04 | $11.52M derived: sum of 3 quarters · filed 2022-03-04 | $20.00M 10-K · filed 2022-03-04 | $35.35M 10-K · filed 2020-02-18 | |
| 2019-09-30 | $8.84M 10-Q · filed 2019-10-31 | $17.76M derived: sum of 2 quarters · filed 2019-10-31 | $26.24M 10-Q · filed 2019-10-31 | |||
| 2019-06-30 | $8.92M 10-Q · filed 2019-08-01 | $17.40M 10-Q · filed 2019-08-01 | ||||
| 2019-03-31 | $8.48M 10-Q · filed 2019-05-03 |